Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy.

Saved in:
Bibliographic Details
Title: Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy.
Authors: Reindl LM; Department of Pediatrics, Experimental Immunology and Cell Therapy, Goethe University Frankfurt, Frankfurt (Main), Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt (Main), Germany., Jalili L; Department of Pediatrics, Experimental Immunology and Cell Therapy, Goethe University Frankfurt, Frankfurt (Main), Germany., Bexte T; Department of Pediatrics, Experimental Immunology and Cell Therapy, Goethe University Frankfurt, Frankfurt (Main), Germany.; University Cancer Center Frankfurt (UCT), University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt (Main), Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt (Main), Germany.; Institute for Transfusion Medicine and Immunohematology, Goethe University Frankfurt, Frankfurt (Main), Germany., Harenkamp S; Institute for Transfusion Medicine and Immunohematology, Goethe University Frankfurt, Frankfurt (Main), Germany., Thul S; Department of Pediatrics, Experimental Immunology and Cell Therapy, Goethe University Frankfurt, Frankfurt (Main), Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt (Main), Germany., Hehlgans S; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt (Main), Germany.; University Hospital, Department of Radiotherapy and Oncology, Goethe University Frankfurt, Frankfurt (Main), Germany., Wallenwein A; Institute for Experimental Pediatric Hematology and Oncology, Goethe University Frankfurt, Frankfurt (Main), Germany., Rothweiler F; Dr Petra Joh-Haus, Frankfurter Stiftung für krebskranke Kinder, Frankfurt (Main), Germany., Cinatl J; Dr Petra Joh-Haus, Frankfurter Stiftung für krebskranke Kinder, Frankfurt (Main), Germany., Michaelis M; Dr Petra Joh-Haus, Frankfurter Stiftung für krebskranke Kinder, Frankfurt (Main), Germany.; School of Natural Sciences, University of Kent, Canterbury, UK., Bonig H; Institute for Transfusion Medicine and Immunohematology, Goethe University Frankfurt, Frankfurt (Main), Germany.; German Red Cross Blood Donation Service Baden-Württemberg-Hessen, Institute Frankfurt, Frankfurt (Main), Germany., Gradhand E; University Cancer Center Frankfurt (UCT), University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt (Main), Germany.; Department of Pediatric and Perinatal Pathology, Dr Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt (Main), Germany., Vogler M; University Cancer Center Frankfurt (UCT), University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt (Main), Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt (Main), Germany.; Institute for Experimental Pediatric Hematology and Oncology, Goethe University Frankfurt, Frankfurt (Main), Germany., Rödel F; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt (Main), Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt (Main), Germany.; University Hospital, Department of Radiotherapy and Oncology, Goethe University Frankfurt, Frankfurt (Main), Germany., Wels WS; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt (Main), Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt (Main), Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt (Main), Germany., Ullrich E; Department of Pediatrics, Experimental Immunology and Cell Therapy, Goethe University Frankfurt, Frankfurt (Main), Germany Evelyn@Ullrichlab.de.; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt (Main), Germany.; University Cancer Center Frankfurt (UCT), University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt (Main), Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt (Main), Germany.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Jul 07; Vol. 13 (7). Date of Electronic Publication: 2025 Jul 07.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2024-011330